Page last updated: 2024-08-04 04:53:58
arsenazo iii
Description
Arsenazo III: Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo. [MeSH]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 135445682 |
| SCHEMBL ID | 1527662 |
| MeSH ID | M0001722 |
Synonyms (37)
| Synonym |
|---|
| 2,2'-((1,8-dihydroxy-3,6-disulfo-2,7-naphthylene)bis(azo)), dibenzene arsonic acid |
| nsc-91528 |
| antineoplastic-91528 |
| nsc91528 |
| 1668-00-4 |
| arsenazo iii, calcium-sensitive dye |
| arsenazo iii |
| 2,7-bis(2-arsonophenylazo)-1,8-dihydroxynaphthalene-3,6-disulfonic acid |
| einecs 216-788-6 |
| 2,7-(bis(2-arsonophenylazo))-1,8-dihydroxynaphthalene-3,6-disulphonic acid |
| ai3-52542 |
| nsc 91528 |
| 2,7-naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy- |
| arsenazo iii sodium salt |
| FT-0622479 |
| AKOS015903602 |
| 3,6-bis((e)-(2-arsonophenyl)diazenyl)-4,5-dihydroxynaphthalene-2,7-disulfonic acid |
| SCHEMBL1527662 |
| J-610012 |
| arsenazo iii free acid |
| arsenazo iii, free acid |
| FT-0696789 |
| 2,2'-(1,8-dihydroxy-3,6-disulfonaphthylene-2,7-bisazo)bisbenzenearsonic acid |
| mfcd00036695 |
| 2,7-bis(2-arsonophenylazo)chromotropic acid |
| arsenazo(iii) |
| arsenazo iii, p.a., 85.0% |
| arsenazo iii, p.a. |
| 2,7-bis(2-arsonophenylazo)-1,8-dihydroxy-3,6-naphthalenedisulfonic acid |
| Q18651591 |
| D88562 |
| A882299 |
| arsenazoiiisodiumsalt |
| STARBLD0016539 |
| arsenazo iii,free acid |
| 3,6-bis[(2-arsonophenyl)diazenyl]-4,5-dihydroxynaphthalene-2,7-disulfonic acid |
| DTXSID201026653 |
Research
Studies (215)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 149 (69.30) | 18.7374 |
| 1990's | 30 (13.95) | 18.2507 |
| 2000's | 19 (8.84) | 29.6817 |
| 2010's | 13 (6.05) | 24.3611 |
| 2020's | 4 (1.86) | 2.80 |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 2 (0.88%) | 5.53% |
| Reviews | 5 (2.20%) | 6.00% |
| Case Studies | 1 (0.44%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 219 (96.48%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|
| gamma-aminobutyric acid | | amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid | human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule | 1982 | 1982 | 42.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| citric acid, anhydrous | | tricarboxylic acid | antimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite | 1982 | 2013 | 26.5 | low | 0 | 1 | 0 | 0 | 1 | 0 |
| chlorine | | halide anion;
monoatomic chlorine | cofactor;
Escherichia coli metabolite;
human metabolite | 1984 | 1985 | 39.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| hydrochloric acid | | chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride | mouse metabolite | 2012 | 2014 | 11.0 | low | 0 | 0 | 0 | 0 | 3 | 0 |
| 4-nitrophenylphosphate | | aryl phosphate | mouse metabolite | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dimethyl sulfoxide | | sulfoxide;
volatile organic compound | alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| hydrogen | | elemental hydrogen;
elemental molecule;
gas molecular entity | antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite | 1984 | 1985 | 39.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| malonic acid | | alpha,omega-dicarboxylic acid | human metabolite | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| phytic acid | | inositol phosphate | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| nickel | | metal allergen;
nickel group element atom | epitope;
micronutrient | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nitrates | | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | | 1984 | 1984 | 40.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| phosphoric acid | | phosphoric acids | algal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| spermidine | | polyazaalkane;
triamine | autophagy inducer;
fundamental metabolite;
geroprotector | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| spermine | | polyazaalkane;
tetramine | antioxidant;
fundamental metabolite;
immunosuppressive agent | 1992 | 1997 | 30.0 | low | 0 | 0 | 3 | 0 | 0 | 0 |
| succinic acid | | alpha,omega-dicarboxylic acid;
C4-dicarboxylic acid | anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 1-anilino-8-naphthalenesulfonate | | aminonaphthalene;
naphthalenesulfonic acid | fluorescent probe | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 2,4-dinitrophenol | | dinitrophenol | allergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 4-aminopyridine | | aminopyridine;
aromatic amine | avicide;
orphan drug;
potassium channel blocker | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| oxyquinoline | | monohydroxyquinoline | antibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 2,5-di-tert-butylhydroquinone | | hydroquinones | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| caffeine | | purine alkaloid;
trimethylxanthine | adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic | 1984 | 1993 | 37.0 | low | 0 | 5 | 1 | 0 | 0 | 0 |
| verapamil | | aromatic ether;
nitrile;
polyether;
tertiary amino compound | | 1987 | 2003 | 29.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| carbonyl cyanide m-chlorophenyl hydrazone | | hydrazone;
monochlorobenzenes;
nitrile | antibacterial agent;
geroprotector;
ionophore | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cetylpyridinium | | pyridinium ion | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| chloroquine | | aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound | anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| pentetic acid | | pentacarboxylic acid | copper chelator | 1995 | 2007 | 21.0 | low | 0 | 0 | 1 | 2 | 0 | 0 |
| erythrosine | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| carbonyl cyanide p-trifluoromethoxyphenylhydrazone | | aromatic ether;
hydrazone;
nitrile;
organofluorine compound | ATP synthase inhibitor;
geroprotector;
ionophore | 1980 | 1996 | 35.5 | low | 0 | 2 | 2 | 0 | 0 | 0 |
| furosemide | | chlorobenzoic acid;
furans;
sulfonamide | environmental contaminant;
loop diuretic;
xenobiotic | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nalidixic acid | | 1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic | antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| 1,2-cyclohexanediamine | | primary aliphatic amine | | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| phenolsulfonphthalein | | 2,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone | acid-base indicator;
diagnostic agent;
two-colour indicator | 1984 | 1986 | 39.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| tetracaine | | benzoate ester;
tertiary amino compound | local anaesthetic | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| tetraethylammonium | | quaternary ammonium ion | | 1984 | 1986 | 38.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| trifluoperazine | | N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines | antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug | 1984 | 1997 | 35.3 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| amifampridine | | aminopyridine | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| dipropylenetriame | | polyazaalkane | algal metabolite;
plant metabolite | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| carbon tetrachloride | | chlorocarbon;
chloromethanes | hepatotoxic agent;
refrigerant | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| aspartic acid | | aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
mouse metabolite;
neurotransmitter | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sucrose | | glycosyl glycoside | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent | 1979 | 1990 | 39.0 | low | 0 | 4 | 1 | 0 | 0 | 0 |
| adenosine diphosphate | | adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate | fundamental metabolite;
human metabolite | 1990 | 1997 | 30.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| edetic acid | | ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid | anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector | 1979 | 2015 | 32.8 | low | 0 | 2 | 1 | 0 | 1 | 0 |
| egtazic acid | | diether;
tertiary amino compound;
tetracarboxylic acid | chelator | 1980 | 1996 | 39.0 | low | 0 | 11 | 3 | 0 | 0 | 0 |
| mannitol | | mannitol | allergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| tert-butylhydroperoxide | | alkyl hydroperoxide | antibacterial agent;
oxidising agent | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| bromthymol blue | | 2,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone | acid-base indicator;
dye;
two-colour indicator | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| rotenone | | organic heteropentacyclic compound;
rotenones | antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| quinoxalines | | mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene | | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| xanthenes | | xanthene | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| bromcresol purple | | 2,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone | acid-base indicator;
dye;
two-colour indicator | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| framycetin | | aminoglycoside | allergen;
antibacterial drug;
Escherichia coli metabolite | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| tetraphenylborate | | | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| lithocholic acid | | bile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid | geroprotector;
human metabolite;
mouse metabolite | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cdta | | organooxygen compound | | 2015 | 2023 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 1 |
| alpha-aminopyridine | | | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| methoxyhydroxyphenylglycol | | methoxybenzenes;
phenols | | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| malachite green | | organic chloride salt | antibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| c.i. 42510 | | | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| durapatite | | | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| stearylamine | | primary aliphatic amine | film-forming compound | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 2-tert-butylhydroquinone | | hydroquinones | food antioxidant | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| amiloride | | aromatic amine;
guanidines;
organochlorine compound;
pyrazines | diuretic;
sodium channel blocker | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| nile blue | | | | 1984 | 1985 | 39.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| dithiothreitol | | 1,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol | chelator;
human metabolite;
reducing agent | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cyclic cmp | | 3',5'-cyclic pyrimidine nucleotide | human metabolite | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| n-methylaspartate | | amino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound | neurotransmitter agent | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| lanthanum | | f-block element atom;
lanthanoid atom;
scandium group element atom | | 1984 | 2000 | 33.7 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| manganese | | elemental manganese;
manganese group element atom | Escherichia coli metabolite;
micronutrient | 1984 | 2002 | 31.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| molybdenum | | chromium group element atom | micronutrient | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| praseodymium | | f-block element atom;
lanthanoid atom | | 1980 | 2000 | 34.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| thorium | | actinoid atom;
f-block element atom | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cadmium | | cadmium molecular entity;
zinc group element atom | | 1986 | 2000 | 31.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| gadolinium | | f-block element atom;
lanthanoid atom | | 1995 | 2006 | 23.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| uranium | | actinoid atom;
f-block element atom;
monoatomic uranium | | 2006 | 2014 | 13.2 | low | 0 | 0 | 0 | 2 | 3 | 0 |
| vanadium | | elemental vanadium;
vanadium group element atom | micronutrient | 1985 | 2008 | 27.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| tricalcium phosphate | | calcium phosphate | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| deuterium | | dihydrogen | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| deuterium oxide | | deuterated compound;
water | NMR solvent | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| molybdate ion | | divalent inorganic anion;
molybdenum oxoanion | Escherichia coli metabolite | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| fluorides | | halide anion;
monoatomic fluorine | | 2013 | 2013 | 11.0 | low | 1 | 0 | 0 | 0 | 2 | 0 |
| calcium oxalate | | organic calcium salt | | 2012 | 2022 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 1 |
| glutamic acid | | glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nigericin | | polycyclic ether | antibacterial agent;
antimicrobial agent;
bacterial metabolite;
potassium ionophore | 1988 | 1998 | 31.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| diltiazem | | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent;
calcium channel blocker;
vasodilator agent | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fomesafen | | aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols | agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fura-2 | | | | 1991 | 1992 | 32.7 | low | 0 | 0 | 3 | 0 | 0 | 0 |
| vanadates | | trivalent inorganic anion;
vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 25-hydroxycholesterol | | 25-hydroxy steroid;
oxysterol | human metabolite | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 2-cresolphthalexon | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| bromates | | bromine oxoanion;
monovalent inorganic anion | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| 3,4-dihydroxyphenylglycol | | catechols;
tetrol | metabolite;
mouse metabolite | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cobalt | | cobalt group element atom;
metal allergen | micronutrient | 1980 | 2002 | 34.7 | low | 0 | 2 | 0 | 1 | 0 | 0 |
| 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid | | polyamino carboxylic acid;
tetracarboxylic acid | chelator | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| quin2 | | | | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fluo-3 | | xanthene dye | fluorochrome | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 1,2-dimyristoylphosphatidylethanolamine | | | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid | | azamacrocycle | chelator;
copper chelator | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| prisma-fil | | | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dodecyloctaethyleneglycol monoether | | hydroxypolyether | | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fenton's reagent | | | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid | | | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tetraphenylphosphonium | | heteroorganic entity;
phosphorus molecular entity;
polyatomic cation | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| inositol 1,4,5-trisphosphate | | myo-inositol trisphosphate | mouse metabolite | 1993 | 1998 | 28.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| quinidine | | cinchona alkaloid | alpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker | 1984 | 1985 | 39.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| ryanodine | | | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| alpha-cyclodextrin | | cyclodextrin | | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| thapsigargin | | butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone | calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| arginine vasopressin | | vasopressin | cardiovascular drug;
hematologic agent;
mitogen | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| oxazolone | | | | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| safranine t | | organic chloride salt | fluorochrome;
histological dye | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| sodium taurodeoxycholate | | bile acid taurine conjugate | human metabolite | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nadp | | | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| valinomycin | | cyclodepsipeptide;
macrocycle | antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore | 1984 | 1988 | 37.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| cobaltous chloride | | cobalt salt;
inorganic chloride | allergen;
calcium channel blocker;
sensitiser;
two-colour indicator | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 6-cyano-7-nitroquinoxaline-2,3-dione | | quinoxaline derivative | | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| alizarin red s | | organic sodium salt;
organosulfonate salt | histological dye | 2004 | 2011 | 16.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| osteoprotegerin | | long-chain fatty acid | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| bilirubin | | biladienes;
dicarboxylic acid | antioxidant;
human metabolite;
mouse metabolite | 1991 | 1992 | 32.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| 11-cis-retinal | | retinal | chromophore;
human metabolite;
mouse metabolite | 1979 | 1982 | 43.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| leukotriene b4 | | dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid | human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent | 1982 | 1983 | 41.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| 1,2-oleoylphosphatidylcholine | | phosphatidylcholine(1+) | | 1985 | 1987 | 38.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| barium | | alkaline earth metal atom;
elemental barium | | 1984 | 1984 | 40.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| rubidium | | alkali metal atom | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| aluminum | | boron group element atom;
elemental aluminium;
metal atom | | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| strontium | | alkaline earth metal atom | | 1984 | 1991 | 36.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| lasalocid | | beta-hydroxy ketone;
monocarboxylic acid;
monohydroxybenzoic acid;
oxanes;
oxolanes;
polyether antibiotic;
secondary alcohol;
tertiary alcohol | bacterial metabolite;
coccidiostat;
ionophore | 1982 | 1984 | 41.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| phosphorus | | monoatomic phosphorus;
nonmetal atom;
pnictogen | macronutrient | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| carbocyanines | | cyanine dye;
organic iodide salt | fluorochrome | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| tetrodotoxin | | azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid | animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker | 1983 | 1987 | 39.2 | low | 0 | 5 | 0 | 0 | 0 | 0 |
| antimycin a | | amidobenzoic acid | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| beta-escin | | | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| gadolinium dtpa | | gadolinium coordination entity | MRI contrast agent | 1995 | 2007 | 23.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| sq-23377 | | cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid | calcium ionophore;
metabolite | 1982 | 1985 | 40.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| dioleoylphosphatidic acid | | 1,2-bis(octadec-9-enoyl)phosphatidic acid | | 1985 | 1986 | 38.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| veratridine | | | | 1982 | 1986 | 40.0 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| calcimycin | | benzoxazole | | 1980 | 1994 | 39.3 | low | 0 | 20 | 3 | 0 | 0 | 0 |
| murexide | | | | 1980 | 1992 | 39.8 | low | 0 | 3 | 1 | 0 | 0 | 0 |
| nad | | organophosphate oxoanion | cofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite | 1984 | 1985 | 39.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| gramicidin a | | | | 1985 | 1986 | 38.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| phosphatidylcholines | | 1,2-diacyl-sn-glycero-3-phosphocholine | | 1984 | 1994 | 36.6 | low | 0 | 6 | 1 | 0 | 0 | 0 |
| atractyloside | | | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| lucifer yellow | | organic lithium salt | fluorochrome | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| potassium bromate | | bromate salt;
potassium salt | flour treatment agent | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| ascorbic acid | | ascorbic acid;
vitamin C | coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| chlortetracycline | | | | 1982 | 1983 | 41.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| oligomycins | | | | 1984 | 1997 | 33.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| nitrophenols | | | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| carboxyatractyloside | | | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cyclosporine | | | | 1997 | 2000 | 25.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| digitonin | | | | 1986 | 1998 | 32.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| apyrase | | | | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cyclic gmp | | 3',5'-cyclic purine nucleotide;
guanyl ribonucleotide | Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1983 | 1988 | 38.0 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| guanosine triphosphate | | guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| hypoxanthine | | nucleobase analogue;
oxopurine;
purine nucleobase | fundamental metabolite | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| allopurinol | | nucleobase analogue;
organic heterobicyclic compound | antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| antipyrylazo iii | | | | 1980 | 1986 | 40.4 | high | 0 | 13 | 0 | 0 | 0 | 0 |
| stilbazochrome-p | | | | 1958 | 1980 | 55.0 | high | 0 | 2 | 0 | 0 | 0 | 0 |
| 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| nk 2367 | | | | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Inhibition of arsenazo III Ca transient with deuterium oxide in frog twitch fibers at a resting sarcomere length.The Japanese journal of physiology, , Volume: 37, Issue:1, 1987
Effects of hypertonic solutions on calcium transients in frog twitch muscle fibres.The Journal of physiology, , Volume: 383, 1987
Minimal latency of calcium release in frog twitch muscle fibres.Proceedings of the Royal Society of London. Series B, Biological sciences, , Oct-22, Volume: 229, Issue:1254, 1986
Excitation-contraction coupling in skeletal muscle.Progress in biophysics and molecular biology, , Volume: 46, Issue:3, 1985
Inhibition of tension development and actomyosin ATPase activity in barnacle muscle by the Ca2+-indicator dye antipyrylazo III.Journal of muscle research and cell motility, , Volume: 6, Issue:3, 1985
Effects of twitch potentiators and repetitive stimulation on arsenazo III Ca-transients in Xenopus skeletal muscle fibers.The Japanese journal of physiology, , Volume: 34, Issue:5, 1984
Arsenazo III calcium transients and latency relaxation in frog skeletal muscle fibres at different sarcomere lengths.The Journal of physiology, , Volume: 355, 1984
Extracellular ions and excitation-contraction coupling in frog twitch muscle fibres.The Journal of physiology, , Volume: 351, 1984
Calcium transients studied under voltage-clamp control in frog twitch muscle fibres.The Journal of physiology, , Volume: 340, 1983
Calcium transients in frog skeletal muscle fibres following conditioning stimuli.The Journal of physiology, , Volume: 339, 1983
Sarcoplasmic reticulum calcium release in frog skeletal muscle fibres estimated from Arsenazo III calcium transients.The Journal of physiology, , Volume: 344, 1983
Dichroic components of Arsenazo III and dichlorophosphonazo III signals in skeletal muscle fibres.The Journal of physiology, , Volume: 331, 1982
Calcium transients evoked by action potentials in frog twitch muscle fibres.The Journal of physiology, , Volume: 333, 1982
Sarcoplasmic Ca2+ transients during the contractile cycle of single barnacle muscle fibres: measurements with arsenazo III-injected fibres.Journal of muscle research and cell motility, , Volume: 3, Issue:1, 1982
Use of metallochromic dyes to measure changes in myoplasmic calcium during activity in frog skeletal muscle fibres.The Journal of physiology, , Volume: 331, 1982
Effects of membrane polarization on sarcoplasmic calcium release in skeletal muscle.Proceedings of the Royal Society of London. Series B, Biological sciences, , Sep-17, Volume: 213, Issue:1190, 1981
A method for studying the depolarization-induced calcium ion release from fragmented sarcoplasmic reticulum.Biochimica et biophysica acta, , Sep-20, Volume: 587, Issue:1, 1979
Spectrophotometric determination of uranium with arsenazo-III in perchloric acid.Chemosphere, , Volume: 63, Issue:7, 2006
[Study on determination of protein with Arsenazo I using resonance light scattering technique].Guang pu xue yu guang pu fen xi = Guang pu, , Volume: 22, Issue:4, 2002
Microdetermination of proteins with the arsenazo-DBN-Al(III) complex by Rayleigh light-scattering technique and application of the method.Fresenius' journal of analytical chemistry, , Volume: 370, Issue:8, 2001
[Measurement of calcium content in the blood and other biological fluids by Arsenazo III complexone].Klinicheskaia laboratornaia diagnostika, , Issue:1, 1999
Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid chromatography and post-column derivatization of gadolinium with Arsenazo III.Journal of pharmaceutical and biomedical analysis, , Volume: 13, Issue:7, 1995
Calcium determination in primary hyperparathyroidism.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, , Volume: 6 Suppl 2, 1991
Stability of two resin combinations used as sealants against toothbrush abrasion and acid challenge in vitro.Acta odontologica Scandinavica, , Volume: 72, Issue:8, 2014
Impact of laminar flow velocity of different acids on enamel calcium loss.Clinical oral investigations, , Volume: 17, Issue:2, 2013
Effect of safflower oil on the protective properties of the in situ formed salivary pellicle.Caries research, , Volume: 46, Issue:5, 2012
Safety/Toxicity (1)
Pharmacokinetics (1)